Filgotinib (JYSELECA)
Ulcerative Colitis, Crohn's Disease
Key Facts
About Gilead
Gilead Sciences is a fully integrated biopharmaceutical giant with a mission to create a healthier world by advancing transformative therapies for serious diseases. It achieved historic success by pioneering curative treatments for hepatitis C and life-sustaining regimens for HIV, establishing a dominant virology franchise. The company's current strategy is to expand its leadership into oncology and inflammation through internal R&D and strategic acquisitions, while maintaining its commitment to health equity and global access.
View full company profileTherapeutic Areas
Other Ulcerative Colitis, Crohn's Disease Drugs
| Drug | Company | Phase |
|---|---|---|
| Novel Immunology Biologics | Boehringer Ingelheim | Phase 2 |
| Novel Immunology Candidate | Teva Pharmaceutical Industries | Phase 3 |